{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:51:47Z","timestamp":1774569107942,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1053\/j.seminhematol.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T20:58:54Z","timestamp":1689368334000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inequalities in access to treatment in Argentina: Differences in management of CLL and multiple myeloma?"],"prefix":"10.1053","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1871-5798","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Mela Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Pavlovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Arturo","family":"Pavlovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2023.07.001_bib0001","unstructured":"https:\/\/www.indec.gob.ar\/ftp\/cuadros\/poblacion\/cnphv2022_resultados_provisionales.pdf."},{"key":"10.1053\/j.seminhematol.2023.07.001_bib0002","unstructured":"https:\/\/www.opc.gob.ar\/en\/health\/characteristics-of-the-argentine-health-care-system."},{"key":"10.1053\/j.seminhematol.2023.07.001_bib0003","unstructured":"https:\/\/www.paho.org\/es\/noticias\/3-12-2019-cuanto-gasta-argentina-salud-analisis-cuentas-sector-publico-privado-seguridad."},{"key":"10.1053\/j.seminhematol.2023.07.001_bib0004","unstructured":"https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthcaresystem\/bulletins\/healthcareexpenditureukhealthaccountsprovisionalestimates\/2022."},{"key":"10.1053\/j.seminhematol.2023.07.001_bib0005","unstructured":"https:\/\/www.cms.gov\/research-statistics-data-and-systems\/statistics-trends-and-reports\/nationalhealthexpenddata\/nhe-fact-sheet."},{"key":"10.1053\/j.seminhematol.2023.07.001_bib0006","unstructured":"https:\/\/psa.gov.ph\/psa-press-release-tags\/philippine-national-health-accounts."},{"issue":"1","key":"10.1053\/j.seminhematol.2023.07.001_bib0007","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/16078454.2020.1833504","article-title":"Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries","volume":"25","author":"Chiattone","year":"2020","journal-title":"Hematology"},{"key":"10.1053\/j.seminhematol.2023.07.001_sbref0008","first-page":"1","article-title":"Epidemiology of hematologic malignancies in real-world settings: findings from the Hemato-Oncology Latin America Observational Registry Study","volume":"5","author":"Tietsche de Moraes Hungria","year":"2019","journal-title":"J Glob Oncol"},{"key":"10.1053\/j.seminhematol.2023.07.001_bib0009","first-page":"34","article-title":"Registro Argentino de Enfermedades Hematol\u00f3gicas (RAEH). Registro LLC","volume":"22","author":"Cabrejo","year":"2018","journal-title":"Hematolog\u00eda"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.07.001_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/bjh.16124","article-title":"Multiple myeloma treatment patterns and clinical outcomes in the Latin America Hemato-Oncology (HOLA) Observational Study, 2008-2016","volume":"188","author":"de Moraes Hungria","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"Suppl","key":"10.1053\/j.seminhematol.2023.07.001_bib0011","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/01.HS9.0000850804.18842.41","article-title":"PB1993: Multiple myeloma Brazilian register \u2013 how about the transplant eligible patients?","volume":"6","author":"Crusoe","year":"2022","journal-title":"Hemasphere"},{"issue":"13","key":"10.1053\/j.seminhematol.2023.07.001_bib0012","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1080\/10428194.2020.1804558","article-title":"Different outcomes for transplant-eligible newly diagnosed multiple myeloma in Latin America according to the public versus private management: a GELAMM study","volume":"61","author":"Pe\u00f1a","year":"2020","journal-title":"Leuk Lymphoma"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:49Z","timestamp":1758522529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0037196323000549"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.07.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inequalities in access to treatment in Argentina: Differences in management of CLL and multiple myeloma?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}